Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

David Ross

Neurology Plantation, FL Medical Doctor

NPI 1063630861 CMS profile 139402

4302 W Broward Blvd, Suite 800, Plantation, FL 33317

Open in the dashboard

General payments

$8,192

405 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$7,375 paid to institutions, not to them · program years 2020–2022

Through program year 2024, David Ross of Plantation, FL is reported in the CMS Open Payments database as having received $8,192 across 405 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $7,375 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 72nd percentile of Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $20 1
2023 General $17 1
2022 General $980 58
2021 General $3,010 185
2020 General $3,054 98
2019 General $1,110 62

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • David Ross
  • Neurology median
  • Middle half of Neurology
  • National median

In program year 2025, general payments to David Ross were reported at $0. Among 11,022 Neurology profiles paid that year, the median was $457 and the middle half received between $118 and $2,344.

Show as a table
Year David Ross Neurology median Middle half National median
2019 $1,110 $474 $118–$2,177 $163
2020 $3,054 $367 $82–$2,309 $114
2021 $3,010 $438 $104–$2,547 $132
2022 $980 $442 $103–$2,388 $149
2023 $17 $464 $119–$2,312 $160
2024 $20 $468 $119–$2,323 $164
2025 $0 $457 $118–$2,344 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Neurelis, Inc. $1,370 11 payments
  2. UCB, Inc. $1,047 53 payments
  3. Eisai Inc. $632 40 payments
  4. Biohaven Pharmaceuticals, Inc. $611 44 payments
  5. AbbVie, Inc. $556 39 payments
  6. Avanir Pharmaceuticals, Inc. $462 30 payments
  7. Sunovion Pharmaceuticals Inc. $413 22 payments
  8. Upsher-Smith Laboratories LLC $314 20 payments
  9. Amgen Inc. $305 15 payments
  10. EMD Serono, Inc. $258 12 payments
  11. Other $2,224 119 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Food and Beverage $6,967 400 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,150 1 payment
  3. Education $75 4 payments
Products named General payments · program years 2019–2024
  1. VALTOCO $1,370 11 payments
  2. NURTEC ODT $739 50 payments
  3. Briviact $662 36 payments
  4. Fycompa $533 34 payments
  5. NUEDEXTA $462 30 payments
  6. APTIOM $413 22 payments
  7. Vimpat $386 17 payments
  8. AIMOVIG $375 19 payments
  9. UBRELVY $263 20 payments
  10. Epidiolex $220 12 payments
  11. Other $3,015 171 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

405 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record